NASDAQ:RLAY | Income Statement | Relay Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$350,000.00$91.17M-$90.82M-$83.71M-$0.41-$0.41202,849,466
2026-03-31$3M$81.59M-$78.59M-$73.29M-$0.41-$0.41179,849,137
2025-12-31$7M$67.63M-$60.63M-$54.89M-$0.31-$0.31612,669
2025-09-30$0.00$80.39M-$80.39M-$74.15M-$0.43-$0.43172,389,209
2025-06-30$677,000.00$77.52M-$76.85M-$70.38M-$0.41-$0.41171,264,622
2025-03-31$7.68M$92.55M-$84.87M-$77.07M-$0.46-$0.46169,233,155
2024-12-31$0.00$84.98M-$84.98M-$76M-$0.42-$0.428,216,116
2024-09-30$0.00$96.37M-$96.37M-$88.11M-$0.63-$0.63140,229,056
2024-06-30$0.00$100.76M-$100.76M-$92.21M-$0.69-$0.69132,821,826
2024-03-31$10.01M$100.37M-$90.36M-$81.39M-$0.62-$0.62130,843,013
2023-12-31-$1,000.00$92.2M-$92.2M-$83.5M-$0.67-$0.67733,411
2023-09-30$25.2M$98.78M-$73.58M-$65.73M-$0.54-$0.54122,231,255
2023-06-30$119,000.00$106.17M-$106.05M-$98.51M-$0.81-$0.81121,680,844
2023-03-31$226,000.00$101.4M-$101.18M-$94.24M-$0.78-$0.78121,320,865
2022-12-31$253,000.00$73.1M-$72.85M-$67.5M-$0.55-$0.552,942,9062,942,906
2022-09-30$344,000.00$86.24M-$85.89M-$84.17M-$0.76-$0.76110,905,940110,905,940
2022-06-30$365,000.00$78.18M-$77.81M-$76.79M-$0.71-$0.71108,644,329108,644,329
2022-03-31$419,000.00$63.14M-$62.72M-$62.05M-$0.57-$0.57108,293,251108,293,251
2021-12-31$567,000.00$68.29M-$67.72M-$67.46M-$0.62-$0.622,536,9382,536,938
2021-09-30$666,000.00$61.66M-$60.99M-$60.83M-$0.66-$0.6692,692,51592,692,515
2021-06-30$844,000.00$194.42M-$193.58M-$193.4M91,939,439
2021-03-31$952,000.00$30.62M$43.36M-$42.41M-$42.18M90,197,579
2020-12-31$32.12M$47.67M$34.99M$35.28M15,852,895
2020-09-30$24.38M$36.61M-$36.61M-$36.08M71,248,846
2020-06-30$21.67M$27.72M-$27.72M-$26.72M4,408,470
2020-03-31$21.7M$26.46M-$26.46M-$24.89M4,153,791
2019-12-31$22.41M$25.83M-$25.83M-$23.91M127,044
2019-09-30$18.26M$21.91M-$21.91M-$19.67M3,556,303
2019-06-30$16.4M$19.91M-$19.91M-$17.54M3,321,045
2019-03-31-$14.18M

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$15.36M$318.09M-$302.74M$0.00-$276.48M-$1.61-$1.61171,586,558
2024-12-31$10.01M$382.48M-$372.47M$0.00-$337.71M-$2.36-$2.36142,867,844
2023-12-31$25.55M$398.55M-$373M$0.00-$341.97M-$2.79-$2.79122,576,527
2022-12-31$1.38M$300.66M-$299.28M$0.00-$290.51M-$2.59-$2.59112,233,649112,233,649
2021-12-31$3.03M$367.73M-$364.7M$0.00-$363.87M-$3.82-$3.8295,136,71995,136,719
2020-12-31$82.65M$99.86M$138.45M-$55.8M$0.00-$52.41M-$5.40-$5.4042,619,58242,619,582
2019-12-31$70.31M$84.05M-$84.05M$0.00-$75.31M3,450,500

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.